• FirefoxUpgrade to the new Firefox »
  •  Dow Down0.79% Nasdaq Up0.16%

    Horizon Pharma plc (HZNP)

    -NasdaqGS
    16.21 0.16(1.00%) Jan 23, 4:00PM EST
    |After Hours : 16.21 0.00 (0.00%) Jan 23, 4:31PM EST
    Add to Portfolio
    Income StatementGet Income Statement for:
    View: Annual Data | Quarterly DataAll numbers in thousands
    Period EndingDec 31, 2013Dec 31, 2012Dec 31, 2011
    Total Revenue 74,016   18,844   6,927  
    Cost of Revenue14,625  11,875  7,267  
    Gross Profit 59,391   6,969   (340)
    Operating Expenses
    Research Development10,084  16,837  15,358  
    Selling General and Administrative92,161  69,005  35,322  
    Non Recurring -   -  69,621  
    Others -   -   -  
    Total Operating Expenses -   -   -  
    Operating Income or Loss (42,854) (78,873) (120,641)
    Income from Continuing Operations
    Total Other Income/Expenses Net(68,094)433  (1,023)
    Earnings Before Interest And Taxes(110,948)(78,440)(121,664)
    Interest Expense39,178  14,525  6,284  
    Income Before Tax(150,126)(92,965)(127,948)
    Income Tax Expense(1,121)(5,171)(14,683)
    Minority Interest -   -   -  
    Net Income From Continuing Ops(149,005)(87,794)(113,265)
    Non-recurring Events
    Discontinued Operations -   -   -  
    Extraordinary Items -   -   -  
    Effect Of Accounting Changes -   -   -  
    Other Items -   -   -  
    Net Income (149,005) (87,794) (113,265)
    Preferred Stock And Other Adjustments -   -   -  
    Net Income Applicable To Common Shares (149,005) (87,794) (113,265)

    Sign Up for a Free Trial to EDGAR Online Premium!
    Get the critical business and financial information you need for more than 15,000 U.S. public companies.
    Sign Up Now - Learn More

    Currency in USD.